Exploratory Study for the Validity of QuQu Scale
Completed
- Conditions
- Alzheimer Dementia
- Registration Number
- NCT02267486
- Lead Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Brief Summary
Examine the construct validity, the group discriminant ability, and the inter-rater reliability of a novel dementia rating scale (QuQu scale: QUick QUestion scale) candidate for the evaluation of patients with Alzheimer Dementia (AD)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 972
Inclusion Criteria
- Alzheimer Dementia (AD) patients and patients with cognitive concern without dementia
- Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.
Exclusion Criteria
- patients with other types of dementia (e.g. vascular dementia, Levy body dementia, frontotemporal dementia)
- patients with other diseases which cause secondary dementia prior to Alzheimer Dementia (AD)
- patients with other severe neurological disease or psychiatric disorder without Alzheimer Dementia (AD)
- patients with other medical conditions where the investigators determine that it is inappropriate for the subject of this study (e.g. inappropriate for the evaluation of dementia rating scale)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Novel Dementia Rating Scale (QUick QUestion Scale) 1 day
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does the QuQu scale assess in Alzheimer's disease dementia patients?
How does the QuQu scale compare to standard dementia rating scales like MoCA or MMSE in terms of group discriminant ability and inter-rater reliability?
Are there specific biomarkers associated with Alzheimer's disease dementia that correlate with QuQu scale outcomes?
What adverse events are commonly observed in Alzheimer's disease dementia patients undergoing standard therapies compared to observational studies?
What are the potential advantages of the QuQu scale over existing diagnostic tools in early-stage Alzheimer's disease dementia detection?
Trial Locations
- Locations (1)
Kagawa University School of Medicine
🇯🇵Kida-gun, Kagawa, Japan
Kagawa University School of Medicine🇯🇵Kida-gun, Kagawa, Japan